NTI Ann: Phase I/II PANDAS/PANS Clinical Trial Meets Primary Endpoint - 6th Oct 2023, 9:25am

annb0t

annb0t

Top 20
NTI Ann: Phase I/II PANDAS/PANS Clinical Trial Meets Primary Endpoint
Price Sensitive: Y
Date: 6th Oct 2023, 9:25am

>>> Read announcement: Google: NTI Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
NTI Ann: NTI to Launch Phase II Clinical Trial in Rett Syndrome - 20th Mar 2023, 9:03am
Replies
0
Views
136
annb0t
annb0t
annb0t
NTI Ann: Phase I/II ASD Clinical Trials Results at 52 Weeks - 17th Mar 2023, 9:45am
Replies
0
Views
116
annb0t
annb0t
annb0t
NTI Ann: First Patient Treated in Phase I/II PANDAS/PANS Trial - 16th Feb 2023, 11:27am
Replies
0
Views
135
annb0t
annb0t
annb0t
NTI Ann: Approval for Additional Phase I/II ASD Trial Extension - 14th Feb 2023, 10:11am
Replies
0
Views
124
annb0t
annb0t
annb0t
NTI Ann: HREC Approval for Phase I/II PANDAS/PANS Clinical Trial - 27th Jan 2023, 9:33am
Replies
0
Views
123
annb0t
annb0t
Top Bottom